United Orthopedic Corporation (4129)
TWSE
86.50
-0.80 (-0.92%)
Closed
Aug 25, 2026
Day's Range
86.1088.20
52 wk Range
82.60131.50
Financial Statements - 4129 - United Orthopedic Corporation
Revenue
5.65B▲ 21.5%
Net Income
571.47M▲ 24.1%Net Margin 10.1%
EBITDA
1.33B▲ 22.3%
Free Cash Flow
264.59M▲ 106.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.65B | 4.65B | 3.92B | 3.16B | 2.57B | 2.34B |
| Cost of Goods | 1.25B | 1.03B | 893.51M | 805.69M | 729.52M | 700.18M |
| Gross Profit | 4.39B | 3.62B | 3.03B | 2.36B | 1.84B | 1.64B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 736.69M | 624.01M | 536.70M | 348.76M | 159.91M | 89.83M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 756.40M | 575.10M | 509.22M | 303.02M | 74.59M | 109.15M |
| Income Tax | 184.92M | 114.72M | 120.91M | 79.44M | 21.71M | 7.84M |
| Net Income | 571.47M | 460.38M | 388.30M | 223.58M | 52.87M | 101.31M |
| EPS Basic | - | 4.74 | 4.5 | 2.84 | 0.37 | 1 |
| EPS Diluted | - | 4.74 | 4.18 | 2.51 | 0.37 | 0.94 |
| Basic Shares Outstanding | - | 96.09M | 84.32M | 78.11M | 77.85M | 78.34M |
| Diluted Shares Outstanding | - | 96.09M | 84.32M | 78.11M | 77.85M | 78.34M |
| Ebit | 802.34M | 618.29M | 553.36M | 327.12M | 92.23M | 140.54M |
| Ebitda | 1.33B | 1.09B | 943.27M | 662.29M | 400.45M | 427.29M |
| Net Income Continuous Operations | 756.40M | 575.10M | 509.22M | 303.02M | 74.59M | 109.15M |
| Minority Interests | -8.97M | -3.95M | -4.10M | -2.04M | -606K | 516K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
